How much is the market price of Bedaquiline per box?
Bedaquiline (Bedaquiline) is a new anti-tuberculosis drug targeting multidrug-resistant Mycobacterium tuberculosis. It is mainly used in the combined treatment of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). Its unique mechanism blocks energy metabolism and cell proliferation by inhibiting the ATP synthase of Mycobacterium tuberculosis, significantly improving the cure rate of drug-resistant tuberculosis. In clinical applications, bedaquiline is usually used as part of a combination treatment regimen with rifampicin, pyrazinamide, aminoglycosides or other second-line drugs to enhance the bactericidal effect and reduce the risk of resistance.

In the domestic market, bedaquiline fumarate tablets have been officially launched and included in the scope of medical insurance, providing an accessible treatment option forMDR-TB patients. The common specifications are 24 tablets of 100mg per box, and the price is about RMB 10,000. Compared with imported or overseas market prices, domestic selling prices are more reasonable, and at the same time, patients' financial burden can be reduced through medical insurance. In overseas markets, such as Russia, the specifications of bedaquiline are usually 188 tablets of 100mg per box, and the price is about 15,000 yuan, but there are certain differences due to exchange rate fluctuations. India and other regions also produce generic versions of bedaquiline, which are cheaper, about more than 2,000 yuan per box, and have basically the same ingredients as the original drug, providing patients with more choices.
The application of bedaquiline is not limited to adultsMDR-TB treatment. In some studies and guidelines, caution is also proposed for young patients and special groups. Correct dosage, regular medication, combined medication and long-term follow-up are the keys to ensuring efficacy and safety. When selecting drugs, patients should comprehensively consider price, accessibility and medical insurance coverage to ensure continuity of treatment and affordability.
Reference materials:https://en.wikipedia.org/wiki/Bedaquiline
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)